Skip to content
Sign in
Science · Global

Hyderabad researchers identify DZIP3’s role in detecting viral RNA

Researchers at Hyderabad’s CSIR-Centre for Cellular and Molecular Biology identified DZIP3 as a protein that detects viral RNA and activates immune defences. The team found that DZIP3 changes shape when it detects viral RNA, and reported that the process protects against SARS-CoV-2, Chikungunya and Japanese Encephalitis.

AI-assisted synthesis · Based on 3 outlets' reporting · Article text read from 2 of 3 outletsHow it's made

View timeline · 6 entries
3 outletsLatest reporting 3 min read
Coverage: Center OnlyL 0 · C 3 · R 0
Updat3 graphic: Hyderabad
Updat3 graphic · Map data: Natural Earth Natural Earth (public domain)

What happened

Key facts

  • The report says DZIP3 detects viral RNA inside a cell.
  • The study was published in The EMBO Journal.
  • The study reports protection against viruses and says the finding could inform therapies to strengthen antiviral immunity.
  • The research was led by Senior Principal Scientist Dr Santosh Chouhan and his group at CCMB.

The brief

Researchers at Hyderabad’s CSIR-Centre for Cellular and Molecular Biology have identified DZIP3 as a protein that detects viral RNA and activates cellular immune defences. The findings describe a mechanism by which cells recognize viral material, with the research team reporting protection against SARS-CoV-2, Chikungunya and Japanese Encephalitis.

The team found that DZIP3 changes shape after detecting viral RNA inside a cell, switching the protein on. Both Hyderabad Mail and Telangana Today describe this RNA-sensing and shape-change process. Telangana Today adds that activated DZIP3 moves to the cell’s mitochondria, where it tags and activates immune defence proteins.

That account says the activated proteins prompt the release of Type I interferons, which it describes as defensive molecules that block viruses from multiplying. Hyderabad Mail’s account instead emphasizes that the process protects against three named viruses and does not detail the mitochondrial step or interferons.

The outlets therefore supply different levels of mechanistic detail rather than competing claims about the protein’s role. The study was led by a group at CSIR-CCMB. Hyderabad Mail identifies the lead researcher as Dr.

Santosh Chauhan, while Telangana Today spells the name Dr Santosh Chouhan; both identify him as a senior principal scientist or Senior Principal Scientist at the centre. Hyderabad Mail says the group published the study in The EMBO Journal, and Telangana Today also names that journal.

Hyderabad Mail places the work in the context of a hypothesis the team had proposed seven years earlier: that some human proteins might both recognize viral genetic material and quickly tag other proteins to initiate an immune response. The new study identifies DZIP3 as performing that kind of two-part role, according to the outlet.

This history connects the current finding to an earlier research idea rather than describing a separate event. Dr. Chauhan said that learning how DZIP3 recognizes viral RNA and activates cellular immunity can improve understanding of human immunity.

The outlets report the protein’s detection and activation role, while Telangana Today provides the more detailed account of the pathway through mitochondria and Type I interferons. The reported work concerns cellular mechanisms and does not describe a treatment or clinical outcome.

Why it matters

  • The specific stakes are cellular: the CSIR-CCMB team reports that DZIP3 detects viral RNA, and Hyderabad Mail says the process protects against SARS-CoV-2, Chikungunya and Japanese Encephalitis.
  • Telangana Today describes a possible mechanism for that defence: activated DZIP3 moves to mitochondria and activates immune proteins, prompting Type I interferons that the outlet says block viral multiplication.
  • The work builds on a hypothesis proposed by Dr. Chauhan’s team seven years earlier about proteins that can detect viral genetic material and rapidly tag other proteins.
  • The findings offer an account of a natural cellular defence mechanism, but the reports do not describe a clinical treatment or patient outcome.

What to watch next

  • Whether further research examines the DZIP3 pathway in relation to the three viruses named by Hyderabad Mail: SARS-CoV-2, Chikungunya and Japanese Encephalitis.
  • Whether subsequent work clarifies the mitochondrial and Type I interferon steps described by Telangana Today.
  • Whether research tests how the earlier hypothesis about proteins that detect viral material and tag other proteins applies beyond the DZIP3 findings.

How it's being covered

Coverage analysisShow details
3 source articles · 3 unique outlets
Outlet political mix: Center Only· 3 Center
Where the outlets are based: Asia 100%
Outlet political mix
Center Only
Left
Center
Right
0 outlets
3 outlets
0 outlets
The marker shows coverage balance: each unique outlet counts once.
Geography
Where the outlets covering this story are based.
3 unique outletsDominant coverage: Asia
Coverage imbalance
  • Coverage is currently concentrated among Center-rated outlets (3 of 3 rated sources); comparatively few Left or Right-rated outlets have published on the event.
  • Coverage is currently concentrated among outlets based in Asia (3 of 3 geographically-identified sources).
How we measure coverage

How outlets' accounts compare

2 framing differences · 1 uncorroborated claim · 2 information gaps
The reports repeat the same account with different emphasis; its central claims are not independently confirmed in the reporting Updat3 read.Compared across 2 reports whose article text Updat3 read; 1 other outlet was checked by headline only.
Framing / emphasis differences
Sources emphasise different angles, actors or consequences of the same reporting.
  • Hyderabad Mail foregrounds the reported protection against SARS-CoV-2, Chikungunya and Japanese Encephalitis and the team’s earlier hypothesis; Telangana Today gives more detail on DZIP3’s movement to mitochondria, immune-protein activation and Type I interferons.
  • Hyderabad Mail spells the lead researcher’s surname “Chauhan,” while Telangana Today spells it “Chouhan.”
Updat3: These are differences of emphasis, not disputes about what is reported. They do not show that the reported claims are true.
One-sided or uncorroborated claims
Claims that come from one party or one source family and are not independently corroborated.
  • Dr. Santosh Chauhan said that understanding how DZIP3 detects viral RNA and activates cellular immunity helps explain human immunity.
Updat3: Not independently corroborated yet — treat as a claim, not an established fact.
Not established by the reporting
Information the available reporting does not contain or confirm. This is a gap, not a disagreement.
  • The reports do not give experimental methods, sample sizes, or results for each of the three named viruses.
  • The reports do not state whether the findings have been tested in people or describe any clinical outcomes.
Updat3: Updat3 cannot conclude anything about this from the current sources.

Timeline

Developments from this story's sources, dated background we compiled and fact-checked, and our earlier coverage. Each row says which.
  1. Alick Isaacs and Jean Lindenmann discovered interferon, a protein involved in cellular resistance to viral infection.
    Background · compiled and fact-checked by Updat3
  2. In 1973, the World Health Organization established its smallpox-eradication programme, one example of the institutional growth of organized virology research.
    Background · from our historical context
  3. CSIR established the Centre for Cellular and Molecular Biology in Hyderabad.
    Background · compiled and fact-checked by Updat3
  4. In 2001, researchers showed that Toll-like receptor 3 (TLR3) recognizes double-stranded RNA and helps trigger antiviral responses.
    Background · from our historical context
  5. In 2004, teams identified RIG-I and MDA5 as cytoplasmic receptors that detect viral RNA and activate interferon signalling.
    Background · from our historical context
  6. The release of SARS-CoV-2’s genome sequence in January 2020 accelerated research into how human cells recognize viral genetic material, building on work that had already identified several RNA-sensing pathways.
    Background · from our historical context

How we got here

The release of SARS-CoV-2’s genome sequence in January 2020 accelerated research into how human cells recognize viral genetic material, building on work that had already identified several RNA-sensing pathways. In 2001, researchers showed that Toll-like receptor 3 (TLR3) recognizes double-stranded RNA and helps trigger antiviral responses.

In 2004, teams identified RIG-I and MDA5 as cytoplasmic receptors that detect viral RNA and activate interferon signalling. These findings established that viral RNA can be sensed inside cells by multiple proteins, rather than by a single universal receptor.

Original sources

3 articles from 3 outlets

Every story links to the reporting it was built from. How we choose sources

Spotted a factual error, a broken link or a misleading summary? Tell us.